Group 1 - Bohai Chemical announced the convening of its 17th meeting of the 10th board of directors on August 26, 2025, to review the 2025 semi-annual report and summary [1] - For the year 2024, Bohai Chemical's revenue composition is as follows: Chemicals account for 98.5%, magnetic cards for 0.92%, printing industry for 0.34%, machinery products for 0.23%, and other businesses for 0.01% [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices for industry-listed companies [1]

Core Viewpoint - Tianjin Bohai Chemical Co., Ltd. conducted a risk assessment report on Tianjin Bohai Group Financial Co., Ltd., confirming its compliance with regulatory requirements and evaluating its operational and risk management capabilities [1][16]. Group 1: Company Overview - Tianjin Bohai Group Financial Co., Ltd. was established on November 4, 1992, as a non-bank financial institution, being the first enterprise group financial company in Tianjin [1]. - The registered capital is 1 billion RMB, with a planned increase to 1.5 billion RMB following approval from the Tianjin Financial Regulatory Bureau [1]. - The company has various membership qualifications, including participation in the national interbank lending center and other financial associations [1]. Group 2: Business Scope - The financial company’s business includes accepting deposits from member units, providing loans, bill discounting, bill acceptance, fund settlement, and various financial advisory services [1]. Group 3: Internal Control and Risk Management - The financial company has established a comprehensive risk management system covering market, credit, operational, liquidity, compliance, and reputational risks [2][3]. - Daily risk monitoring focuses on key indicators such as capital adequacy ratio, liquidity ratio, and non-performing asset ratio [3]. - The governance structure includes a board of directors, supervisory board, and senior management, ensuring effective oversight and compliance [3]. Group 4: Financial Performance - As of June 30, 2025, the total assets of the financial company reached 7.156 billion RMB, a 24.55% increase from the previous year [14]. - The total liabilities amounted to 5.284 billion RMB, reflecting a 25.10% growth year-on-year [14]. - The company achieved an operating income of 84.2315 million RMB in the first half of 2025, meeting 49.32% of its annual budget target [14]. Group 5: Regulatory Compliance - The financial company adheres to the regulations set forth by the China Banking and Insurance Regulatory Commission, with all supervisory indicators within acceptable limits [15][16]. - The company has not identified any significant deficiencies in its risk management framework since its establishment [16].

Core Viewpoint - The report details the fundraising activities and the usage of raised funds by Tianjin Bohai Chemical Co., Ltd. for the period ending June 30, 2025, highlighting the management, allocation, and changes in investment projects. Fundraising Overview - The company raised a total of RMB 706.02 million through a non-public offering of 183,381,314 shares at RMB 3.85 per share, with the funds verified by an independent auditor [1][2]. - The funds are managed under specific regulations and stored in dedicated accounts to ensure proper usage and efficiency [1][2]. Fund Management - The company has established a fundraising management method to ensure that the funds are used efficiently and in compliance with relevant regulations [1][2]. - A four-party supervision agreement was signed with independent financial advisors and banks to oversee the management of the raised funds [1][2]. Fund Usage - As of June 30, 2025, the total amount of funds used was RMB 281.55 million, with RMB 200 million temporarily allocated to supplement working capital and RMB 281.55 million invested in projects [1][2][3]. - The remaining balance of the raised funds was RMB 256.78 million after accounting for the temporary working capital allocation [1][2][3]. Project Changes - The company changed the investment focus from the "Propane Dehydrogenation Unit Technology Transformation Project" to the "Acrylic Ester and Superabsorbent Resin New Material Project" due to market conditions affecting the original project [2][6]. - The new project is located in the Tianjin Port Free Trade Zone and is currently being implemented as planned [2][6]. Idle Fund Management - The company has not engaged in cash management activities for idle funds during the reporting period [3]. - A resolution was passed to use up to RMB 350 million of idle funds for cash management, with a rolling usage period of up to 12 months [2][3]. Investment Project Status - The company has not transferred or replaced any investment projects with the raised funds, and the projects are being executed according to the planned schedule [1][2][3]. - The company has confirmed that the actual usage of funds aligns with the disclosures in periodic reports, with no significant discrepancies noted [1][2].

Core Viewpoint - The report provides an audit of Tianjin Bohai Chemical Co., Ltd.'s fundraising activities and the actual use of raised funds for the first half of 2025, confirming compliance with regulations and accurate reporting of fund usage [1][2]. Fundraising Overview - The company raised a total of RMB 706,018,058.90 through a non-public offering of 183,381,314 shares at RMB 3.85 per share, with net proceeds amounting to RMB 69,895.79 million after deducting issuance costs [2][3]. - The funds are managed under a specific management plan to ensure proper usage and efficiency, with dedicated accounts for storage [2][3]. Fund Storage and Usage - As of June 30, 2025, the total balance of the raised funds was RMB 25,677.51 million after accounting for various expenditures, including RMB 20,000 million temporarily used for working capital and RMB 28,154.60 million invested in projects [2][3]. - The company has established a four-party supervision agreement for the management of the raised funds, ensuring compliance with regulatory requirements [2][3]. Project Investment and Changes - The company has changed the investment focus from the "Propane Dehydrogenation Unit Technical Transformation Project" to the "Acrylic Ester and Super Absorbent Resin New Material Project" due to market conditions affecting the feasibility of the original project [2][3][5]. - The new project is currently being implemented as planned, with no significant changes in feasibility reported [5][6]. Idle Fund Management - The company has not engaged in cash management activities for idle funds during the reporting period, and no permanent use of excess funds for working capital or loan repayment has occurred [4][6]. - A temporary use of up to RMB 20,000 million of idle funds for working capital was approved, with a commitment to return the funds to the dedicated account as needed [4][6].

Group 1 - The company reported a revenue of 1.961 billion yuan for the first half of 2025, representing a year-on-year decline of 21.73% [1] - The net profit attributable to shareholders was a loss of 359 million yuan [1] - The non-recurring net profit also showed a loss of 357 million yuan, with basic earnings per share at -0.32 yuan [1]

Group 1 - The company, Bohai Chemical, announced the approval of its 2025 semi-annual report and summary by the 15th meeting of the 10th Supervisory Board [2]

（文章来源：证券日报） 证券日报网讯 8月26日晚间，渤海化学发布公告称，公司第十届董事会第十七次会议审议通过了《天津 渤海化学股份有限公司2025年半年度报告及摘要》等多项议案。 ...

证券代码：600800 证券简称：渤海化学 编号：临 2025-041 天津渤海化学股份有限公司 关于第十届监事会第十五次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、天津渤海化学股份有限公司 2025 年半年度报告及摘要 表决结果：同意 5 票；反对 0 票；弃权 0 票。 二、关于 2025 年 1-6 月募集资金实际存放与使用情况的专项报 告 表决结果：同意 5 票；反对 0 票；弃权 0 票。 详见公司同日刊登于上海证券交易所和《上海证券报》《中国证 券报》的《天津渤海化学股份有限公司关于 2025 年 1-6 月募集资金 实际存放与使用情况的专项报告》（公告号：临 2025-040）。 三、天津渤海化学股份有限公司关于天津渤海集团财务有限责任 公司风险持续评估报告的议案 表决结果：同意 5 票；反对 0 票；弃权 0 票。 特此公告。 监 事 会 天津渤海化学股份有限公司 天津渤海化学股份有限公司第十届监事会第十五次会议于 2025 年 8 月 19 日以电话及电子邮件方式通知各位监事，会议于 ...

一、天津渤海化学股份有限公司 2025 年半年度报告及摘要 本议案已经公司十届十四次董事会审计委员会事前认可并同意 提交董事会。 证券代码：600800 证券简称：渤海化学 编号：临 2025-039 天津渤海化学股份有限公司 关于第十届董事会第十七次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 天津渤海化学股份有限公司（以下简称"公司"）第十届董事会 第十七次会议于 2025 年 8 月 19 日以电话及电子邮件方式通知各位董 事，会议于 2025 年 8 月 26 日 9:00 在公司召开，会议应到董事 9 人， 实到董事 9 人，公司高管人员及部分监事会成员列席了本次会议。会 议由董事长郭子敬先生主持，符合《公司法》《公司章程》的有关规 定，会议审议通过了如下议案： 三、天津渤海化学股份有限公司关于天津渤海集团财务有限责任 公司风险持续评估报告的议案 本议案已经公司十届十四次董事会审计委员会、2025 年第二次 独立董事专门会议事前认可并同意提交董事会。 表决结果：同意 9 票；反对 0 票；弃权 0 ...

人民财讯8月26日电，渤海化学（600800）8月26日晚间披露2025年半年报，上半年实现营业收入19.61 亿元，同比下降21.73%；归母净利润-3.59亿元；基本每股收益-0.32元。 ...